| 2011 | Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. | HEPATOLOGY |
| 2019 | Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure | HEPATOLOGY |
| 2014 | Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. | HEPATOLOGY |
| 2011 | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | HEPATOLOGY |
| 2020 | RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
| HEPATOLOGY |
| 2010 | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis
| HEPATOLOGY |
| 2016 | Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011) | HEPATOLOGY |
| 2020 | Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study | HEPATOLOGY |
| 2019 | Should LR-M and LR-TIV Remain Separate Categories in LI-RADS? | HEPATOLOGY |
| 2015 | Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma | HEPATOLOGY |
| 2023 | Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study | HEPATOLOGY |
| 2012 | Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma
| HEPATOLOGY |
| 2018 | Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update? | HEPATOLOGY |
| 2011 | Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice
| HEPATOLOGY |
| 2008 | Surface markers for the murine oval cell response
| HEPATOLOGY |
| 2007 | Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis | HEPATOLOGY |
| 2011 | The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice
| HEPATOLOGY |
| 2016 | The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17 | HEPATOLOGY |
| 2003 | Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | HEPATOLOGY |
| 2016 | Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial | HEPATOLOGY |
| 2007 | Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
| 2015 | Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy | HEPATOLOGY |
| 2000 | "Vascular profiles" of regenerative and dysplastic nodules | Hepatology |
| 2020 | Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma | HEPATOLOGY |
| 2021 | YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation | HEPATOLOGY |
| 2016 | Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma
| HEPATOLOGY |
